Five prominent pharma CEO shuffles
This article was originally published in Scrip
Executive Summary
Following the shock sacking of Sanofi CEO Christopher Viehbacher (scripintelligence.com, 29 October 2014), which blasted more than $18bn of the French drugmaker's market cap, Scrip has rounded up five of the most dramatic CEO departures and appointments to affect big pharma in recent years.